Depression and Obesity


      This case study focuses on a 21-year-old woman with a history of obesity and a psychiatric history of chronic persistent depression since high school seeking alternative treatments for her depression and her depressive-related weight issues. The discussion explores issues of depression and the associated weight concerns with treatment options in the adult patient. The client was prescribed bupropion and naltrexone to manage her depression and eating behaviors that contributed to her obesity. This article reviews the effects of depression on appetite and methods of managing both comorbidities.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Journal for Nurse Practitioners
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        7th ed. APA, 2019
        • National Institute of Mental Health
        Eating disorders. 2016.
        • Hoglund R.
        • Oyvind O.
        • Winberg S.
        Tryptophan metabolic pathways and brain serotonergic activity: a comparative review.
        Front Endocrinol (Lausanne). 2019; 10: 158
        • Haleem D.
        Improving therapeutics in anorexia nervosa with tryptophan.
        Life Sci. 2017; 178: 87-93
        • Gadde K.
        • Parker C.
        • Maner L.
        • et al.
        Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
        Obes Res. 2001; 9: 544-551
        • Crow S.
        Pharmacologic treatment of eating disorders.
        Psychiatr Clin North Am. 2019; 42: 253-262
        • Kriikku P.
        • Ojanpera I.
        The relationship between bupropion and suicide in post-mortem investigations.
        Forensic Sci Int. 2016; 266: 343-348
        • Himmerich H.
        • Treasure J.
        Psychopharmacological advances in eating disorders.
        Expert Rev Clin Pharmacol. 2018; 11: 95-108
        • Castelnuovo G.
        • Pietrabissa G.
        • Manzoni G.
        • et al.
        Cognitive behavioral therapy to aid weight loss in obese patients: current perspectives.
        Psychol Res Behav Manag. 2017; 10: 165-172
        • Petrovic M.
        • De Paepe P.
        • Van Bortel L.
        Pharmacotherapy of depression in old age.
        Acta Clin Belg. 2005; 60: 150-156
        • Brooke L.
        • Benedetti A.
        • Thombs D.
        Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis.
        BMJ. 2019; 365: I1476
        • Posner K.
        • Brown G.
        • Stanley B.
        • et al.
        The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.
        Am J Psychiatry. 2011; 168: 1266-1277
        • Trojanowski P.
        • Fischer S.
        The role of depression, eating disorder symptoms, and exercise in young adults’ quality of life.
        Eat Behav. 2018; 31: 68-73
        • Cook B.
        • Wonderlich S.
        • Mitchell J.
        • Thompson R.
        • Sherman R.
        • McCallum K.
        Exercise in eating disorders treatment: systematic review and proposal of guidelines.
        Med Sci Sports Exerc. 2016; 48: 1408-1414


      Ann Lurati, DNP, MPH, AGACNP, is a nursing lecturer at California State University in Monterey Bay and can be contacted at [email protected]